Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer

By afschroeder • April 18, 2026

Unterrainer LM, Ndlovu H, Hope TA, Unterrainer M, Czernin J, Sathekge M, Calais J. Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer. J Nucl Med. 2026 Apr 16:jnumed.125.271598. doi: 10.2967/jnumed.125.271598. Epub ahead of print. PMID: 41991337.

Tags: Cardiology/Epi, CHAARTED, mHSPC, patient outcome, PET/CT, PSMA, Publications, volume of disease

Biodegradable devices for transcatheter patent foramen ovale closure: current evidence and future directions

Khan A, Khan M, Thyagaturu H, Shafi N, Muhibullah F, Kanwal K, Irshad K, Fonarow GC, Sattar Y. Biodegradable devices for transcatheter patent foramen ovale[...]

Shielded by Scar?: Transvenous Lead Extraction Outcomes After Prior Sternotomy

Lin CP, Boyle NG. Shielded by Scar?: Transvenous Lead Extraction Outcomes After Prior Sternotomy. JACC Clin Electrophysiol. 2026 Apr 6:S2405-500X(26)00256-2. doi: 10.1016/j.jacep.2026.03.013. Epub ahead of[...]

Measuring nephron number in the healthy and diabetic rat kidney in vivo using MRI without contrast agents

Baldelomar EJ, Charlton JR, Keilhoz S, Kohn B, Wilson LD, Xiong LI, Garfinkel A, Bennett KM. Measuring nephron number in the healthy and diabetic rat[...]